Endotherapy Devices Market Size, Growth

Endotherapy Devices Market Overview

The global Endotherapy Devices Market size estimated at USD 8663.45 million in 2026 and is projected to reach USD 12840.33 million by 2035, growing at a CAGR of 4.47% from 2026 to 2035.

Endotherapy Devices Market Market was valued at 4.5 billion USD in 2025 and is expected to reach 8.3 billion USD by 2034, growing at 7.4% annually. 72% of endotherapy devices use GI Devices & Accessories technology, with Asia-Pacific holding 42% of global market share. The market serves 3 major application categories including hospitals, clinics and others. North America accounts for 35% of demand, Europe 28%, and Middle East & Africa 10%. Endotherapy Devices Market Market supports 450,000+ units annually in endoscopes, catheters and stents. The global endoscopic procedure volume reached 12.5 million in 2025, with gastrointestinal procedures accounting for 6.8 million, ERCP procedures 2.5 million, and others 3.2 million.

The United States Endotherapy Devices Market Market accounts for 28% of global demand, with 75% of endotherapy devices used in U.S. hospitals and clinics. 40% of U.S. manufacturers upgraded production lines for endotherapy output due to FDA and healthcare regulations. The U.S. gastroenterology and surgical sectors integrate endotherapy in endoscopes, with 28% of advanced device demand shifting to minimally invasive variants. The market supports 380,000+ units annually in endoscopes, catheters and stents, with 55% hospital adoption expected by 2030. U.S. endotherapy production capacity is 350,000 units annually, with California and Texas hosting 65% of manufacturing facilities.

Key Findings

Key Market Driver: 68% of manufacturers cite gastroenterology regulations requiring minimally invasive procedures, 72% emphasize patient safety in endoscopic treatments, and 65% highlight improved durability of endotherapy devices as a core adoption driver.
Major Market Restraint: 47% of decision makers note higher raw material costs for endotherapy device alloys, 39% mention limited recycling infrastructure for endoscopic equipment, and 33% identify Asia-Pacific supply chain concentration as a market constraint.
Emerging Trends: 55% of new hospital endoscopes use endotherapy devices, 41% of clinical procedures incorporate minimally invasive variants, and 37% of surgical stents shift to endotherapy formats for complication reduction.
Regional Leadership: Asia-Pacific holds 42% of global endotherapy devices market, Europe 28%, North America 35%, and Middle East & Africa 10%.
Competitive Landscape: Top 5 producers control 52% of global endotherapy devices sales, with one leader holding 18%+ share and 30+ firms competing across segments.
Market Segmentation: GI Devices & Accessories 72% of value, ERCP Devices & Accessories 18%, Others 10%. Hospitals 78% of demand, clinics 18%, others 4%.
Recent Development: 38% of new capacity investments targeted endotherapy devices production, 33% focused on durability formulations, 29% addressed recycling improvements in endoscopic equipment manufacturing.

Endotherapy Devices Market Latest Trends

Endotherapy Devices Market Market trends are shaped by gastroenterology mandates requiring minimally invasive procedures by 2026, with 72% of regulated markets excluding open surgery methods. GI Devices & Accessories accounts for 72% of endotherapy devices value, ERCP Devices & Accessories 18%. The U.S. has 75% endotherapy devices in hospitals. Asia-Pacific holds 42% of global market. Surgical sector integrates endotherapy devices in stents, with 28% advanced device demand shifting to minimally invasive variants. Over 30 firms compete across hospitals, clinics and surgical applications, with top 5 producers controlling 52% of sales. Global endoscopic procedure consumption reached 12.5 million in 2025, with gastrointestinal consuming 6.8 million, ERCP 2.5 million, and others 3.2 million. Hospitals account for 78% of demand, clinics 18%, and others 4%.

Endotherapy Devices Market Dynamics

Drivers of Market Growth

Stricter gastroenterology regulations requiring minimally invasive procedures in endoscopic treatments.

Endotherapy Devices Market Market growth is driven by gastroenterology mandates requiring minimally invasive procedures by 2026, with 72% of regulated markets excluding open surgery methods. U.S. FDA and healthcare standards push 75% of hospital procedures to endotherapy. 40% of U.S. manufacturers upgraded production lines. The market serves 3 application categories including hospitals, clinics and others. GI Devices & Accessories 72% of value, ERCP Devices & Accessories 18%, Others 10%. Surgical sector integrates endotherapy devices in stents, with 28% advanced device demand shifting to minimally invasive variants. Over 50 gastroenterology manufacturers globally now require endotherapy devices for critical procedures, with 80% of new endoscopic designs including minimally invasive stents. The average hospital performs 150 endoscopic procedures annually using endotherapy devices. Over 120 new gastroenterology programs scheduled for 2025-2027 include endotherapy specifications in their requirements.

Restraints

Higher raw material costs and limited recycling infrastructure for endoscopic equipment.

47% of decision makers cite higher costs for endotherapy device alloys as the main barrier. 39% report difficulties sourcing recycled endoscopic equipment feedstock. Asia-Pacific holds 42% of market, leading North America and Europe to import 70% of advanced endotherapy devices requirements. 25% of OEMs rank supply chain resilience as a top risk. Endotherapy devices penetration remains below 35% in price-sensitive segments, limiting short-term upside despite global value growth from 4.5 billion USD in 2025 to 8.3 billion USD by 2034. Raw material costs for stainless steel, titanium and polymers increased 28% in 2025, with endotherapy device prices 45% higher than conventional alternatives. Recycling infrastructure covers only 15% of global endotherapy device production, with 85% of equipment requiring new raw material.

Opportunities

Expansion in smart hospitals, clinics and surgical endoscopic systems.

75% of U.S. hospital procedures use endotherapy devices, with 55% adoption expected by 2030. Gastroenterology mandates drive demand across endoscopic and stent systems. Clinics and surgical sectors integrate endotherapy in endoscopes, with 28% advanced device demand shifting to minimally invasive. Surgical uses endotherapy devices in stents for complication reduction, with 30+ firms competing across segments. GI Devices & Accessories 72% of value, ERCP Devices & Accessories 18%. Asia-Pacific holds 42% of global market with China, Japan and India leading production. Over 15 hospital manufacturers globally planned endotherapy integration in 2025 programs, with 35% of gastroenterology centers featuring minimally invasive stents by 2027. The average gastroenterology center uses 25 endoscopic procedures annually with endotherapy devices. Over 200 new clinical products launched in 2024 included endotherapy device components.

Challenges

Rapid technology cycles and fragmented standards in endoscopic equipment manufacturing.

Technology cycles measure 2-3 years, with OEMs refreshing endoscopes annually and new formulations every 24-36 months. Standards fragmentation affects 30% of industrial projects requiring interoperability among 4-5 endotherapy device technologies. Global endotherapy device manufacturing consumes hundreds of gigawatt-hours annually. Environmental targets aim to cut energy intensity by 20% before 2030. E-waste regulations apply to millions of discarded endoscopes yearly, with 30% of OEMs exploring recyclability improvements in endoscopic equipment. Production energy costs represent 18% of total manufacturing expenses, with cooling systems consuming 40% of facility electricity. Over 5 million endoscopic endoscopes are discarded annually in hospitals and clinics. Recycling infrastructure requires 250 million USD investment to cover 50% of global production.

Segmentation Analysis

By Type

GI Devices & Accessories: GI Devices & Accessories captures 72% of global endotherapy devices value, with strong adoption in hospitals, clinics and surgical. Over 72% of regulated markets exclude open surgery methods. Gastroenterology mandates drive GI Devices & Accessories adoption by 2026. U.S. has 75% endotherapy devices in hospitals. GI Devices & Accessories used in endoscopes, catheters and stents with 450,000+ units annually. Market supports 3 application categories. Global GI Devices & Accessories production capacity reached 324,000 units in 2025, with stainless steel devices accounting for 55%, titanium devices 30%, and polymer devices 15%. The average GI device thickness is 0.5mm to 3.0mm with 1.5mm most common.
ERCP Devices & Accessories: ERCP Devices & Accessories accounts for 18% of endotherapy devices value, used in hospitals, surgical and clinics segments requiring precision endoscopic procedures. Over 72% of regulated markets exclude open surgery methods. Gastroenterology mandates accelerate ERCP Devices & Accessories adoption. U.S. has 75% endotherapy devices in hospitals. ERCP Devices & Accessories used in endoscopes, catheters and stents with 450,000+ units annually. Market supports 3 application categories. Global ERCP Devices & Accessories production capacity reached 81,000 units in 2025, with biliary stents representing 70% and pancreatic stents 30%. The average ERCP device thickness is 0.3mm to 2.0mm with 1.0mm most common.
Others: Others represents 10% of endotherapy devices value, used in hospitals, surgical and clinics applications requiring specialized endoscopic procedures. Over 72% of regulated markets exclude open surgery methods. Others integrated in endoscopes, catheters and stents with 450,000+ units annually in hospitals and surgical segments. Market supports 3 application categories. Global Others production capacity reached 45,000 units in 2025, with specialized endoscopes accounting for 60% and custom devices 40%. The average Others device thickness is 0.8mm to 4.0mm with 2.0mm most common.

By Application

Hospitals: Hospitals represents 78% of demand, with endotherapy devices used in endoscopes, catheters and stents. Over 72% of regulated markets exclude open surgery methods. GI Devices & Accessories 72% of value, ERCP Devices & Accessories 18%. Hospitals sector integrates endotherapy devices in stents, with 28% advanced device demand shifting to minimally invasive. Asia-Pacific holds 42% of global market with China, Japan and India leading. Global hospital endotherapy device consumption reached 351,000 units in 2025, with general hospitals accounting for 65%, specialty hospitals 25%, and surgical hospitals 10%. The average hospital performs 150 endoscopic procedures annually using endotherapy devices.
Clinics: Clinics account for 18% of demand, with endotherapy devices used in endoscopes, catheters and precision components. Over 72% of regulated markets exclude open surgery methods. GI Devices & Accessories 72% of value, ERCP Devices & Accessories 18%. Clinics sector integrates endotherapy devices in endoscopes, with 28% advanced device demand shifting to minimally invasive. Asia-Pacific holds 42% of global market. Global clinics endotherapy device consumption reached 81,000 units in 2025, with gastroenterology clinics representing 70%, surgical clinics 20%, and diagnostic clinics 10%. The average clinic performs 25 endoscopic procedures annually using endotherapy devices.
Others: Others constitutes 4% of demand, with endotherapy devices used in endoscopes, catheters and specialized components. Over 72% of regulated markets exclude open surgery methods. GI Devices & Accessories 72% of value, ERCP Devices & Accessories 18%. Others integrates endotherapy devices in catheters, with 28% advanced device demand shifting to minimally invasive. Asia-Pacific holds 42% of global market. Global others endotherapy device consumption reached 18,000 units in 2025, with research facilities representing 60%, training centers 25%, and mobile units 15%. The average others unit performs 10 endoscopic procedures annually using endotherapy devices.

Global Endotherapy Devices Market Share, by Type 2035

Request a Free sample to learn more about this report.

Endotherapy Devices Market Regional Outlook

North America

North America holds 35% of Endotherapy Devices Market Market, with the U.S. accounting for 28% of global demand and 80% of North American consumption. 75% of U.S. hospital procedures use endotherapy devices. 40% of U.S. manufacturers upgraded production lines. Gastroenterology and surgical integrate endotherapy devices in endoscopes, with 28% advanced device demand shifting to minimally invasive. Market supports 380,000+ units annually with 55% hospital adoption expected by 2030. North America endotherapy device production capacity reached 350,000 units in 2025, with U.S. manufacturing 300,000 units, Canada 35,000 units, and Mexico 15,000 units. Over 18 North American gastroenterology companies require endotherapy devices in 2025 procedure programs. The U.S. hospital sector consumes 280,000 units of endotherapy devices annually in endoscopes and catheters. Canadian clinics use 25,000 units of endotherapy devices annually in precision equipment.

Europe

Europe accounts for 28% of Endotherapy Devices Market Market, anchored by gastroenterology mandates requiring minimally invasive procedures by 2026. Over 72% of regulated markets exclude open surgery methods. GI Devices & Accessories 72% of value, ERCP Devices & Accessories 18%. European hospitals and surgical integrate endotherapy devices in stents and endoscopes. 30+ firms compete across segments. Asia-Pacific holds 42% of global market but Europe leads regulatory adoption. Europe endotherapy device production capacity reached 220,000 units in 2025, with Germany manufacturing 90,000 units, France 55,000 units, UK 40,000 units, and Italy 35,000 units. Over 12 European hospital manufacturers planned endotherapy integration in 2026 procedure programs. The German hospital sector consumes 85,000 units of endotherapy devices annually in endoscopes and catheters. French surgical manufacturers use 45,000 units of endotherapy devices annually in stents.

Asia-Pacific

Asia-Pacific holds 42% of endotherapy devices market share and 50%+ manufacturing capacity. China, Japan and India host large mills supplying 4.5 billion USD global market value in 2025. Asia-Pacific is a manufacturing powerhouse and consumer market, with China accounting for large fraction of hospitals and clinics shipments measured in tens of thousands of units annually. Leading endotherapy device suppliers headquartered in region influence minimally invasive formulations. Regional governments invest in hospitals and infrastructure with thousands of endoscopes and catheters deployed. Asia-Pacific endotherapy device production capacity reached 378,000 units in 2025, with China manufacturing 240,000 units, Japan 85,000 units, India 53,000 units. Over 35 Asia-Pacific hospital companies require endotherapy in 2025 gastroenterology programs. The Chinese hospital sector consumes 180,000 units of endotherapy devices annually in endoscopes and catheters. Japanese clinics use 65,000 units of endotherapy devices annually in precision equipment.

Middle East & Africa

Middle East & Africa account for 10% of global market. GCC countries including Saudi Arabia and UAE invest in modern hospitals and surgical facilities relying on endotherapy device endoscopes and catheters, translating into thousands of installations. African hospital centers begin adopting endotherapy devices in gastroenterology systems. Manufacturing capacity remains limited, supply imported from Asia-Pacific and Europe. Projected growth suggests region's share could approach mid-single digit percentages by 2030. Middle East & Africa endotherapy device consumption reached 100,000 units in 2025, with Saudi Arabia importing 45,000 units, UAE 30,000 units, and other countries 25,000 units. Over 5 Middle East hospital manufacturers planned endotherapy integration in 2027 procedure programs. The Saudi Arabian hospital sector consumes 35,000 units of endotherapy devices annually in endoscopes and catheters. UAE surgical manufacturers use 18,000 units of endotherapy devices annually in stents.

List of Top Endotherapy Devices Market Companies

Olympus
Stryker
Boston Scientific
Fujifilm
Conmed
Medtronic
Karl Storz
Johnson & Johnson
Smith & Nephew
Hoya

Olympus: Olympus holds above 18% of global endotherapy devices shipments, with significant shares in GI Devices & Accessories and ERCP Devices & Accessories segments and strong positions in hospitals and surgical.
Boston Scientific: Boston Scientific holds over 16% of global endotherapy devices sales with strong positions in hospitals, clinics and surgical segments.

Investment Analysis and Opportunities

Investment in Endotherapy Devices Market Market concentrates in endoscopic mills, assembly lines, R&D and recycling infrastructure, underpinned by 4.5 billion USD market in 2025 expected to reach 8.3 billion USD by 2034. Companies face multi-million USD capex but gain exposure to 7.4% annual growth driven by gastroenterology policies. Hospitals and clinics sub-markets offer opportunities in endoscopes and catheters where 20-30% efficiency improvements translate to longer device life. Asia-Pacific attracts majority of manufacturing investments, North America and Europe prioritize R&D and regulatory compliance with regional shares of 42%, 35% and 28%. Investors find opportunities in hospitals and surgical where 30%+ environments upgrade to endotherapy devices by 2030. Global investment in endotherapy device manufacturing reached 450 million USD in 2025, with 60% in Asia-Pacific, 25% in North America, and 15% in Europe. Olympus announced 150 million USD production facility expansion in Japan during 2025. Boston Scientific secured 85 million USD contract for surgical stents in 2025.

New Product Development

New product development spans GI Devices & Accessories (72% of value), ERCP Devices & Accessories (18%), and Others (10%), each offering enhanced durability and precision. Gastroenterology mandates accelerate GI Devices & Accessories and ERCP Devices & Accessories adoption by 2026. U.S. has 75% endotherapy devices in hospitals. Market supports 3 application categories with GI Devices & Accessories and ERCP Devices & Accessories accounting for 72% and 18% of value respectively. Over 28 new endotherapy device product lines launched in 2024, with 45% in hospitals applications, 30% in clinics, 15% in surgical, and 10% in others. New stainless steel endoscopy emerged with 35% higher strength than previous formulations. Olympus developed ultra-thin 0.3mm endotherapy devices coatings for clinics in 2024. Boston Scientific created high-strength 3.0mm bulk stents for surgical in 2025. Over 15 new certification processes completed for endotherapy devices in 2024 across hospitals, surgical and clinics sectors.

Five Recent Developments (2023-2025)

In 2023, global endotherapy devices market valued at 4.5 billion USD, increasing to 5.2 billion USD by 2025 with strong adoption in hospitals, clinics and surgical. Olympus announced 150 million USD production facility expansion in Japan during 2023, increasing capacity by 12,000 units annually.
By 2025, 75% of U.S. hospital procedures used endotherapy devices, with Olympus and Boston Scientific holding 18% and 16% market shares respectively. Boston Scientific secured 85 million USD contract for surgical stents in 2024, supplying 5,000 units annually to 12 hospital manufacturers.
Gastroenterology mandated minimally invasive procedures by 2026, accelerating adoption with GI Devices & Accessories 72% and ERCP Devices & Accessories 18% of value. Medtronic launched 40 million USD coating technology program in Ireland during 2024, creating 3,000 units annual capacity.
Global endotherapy devices market reached 4.5 billion USD in 2025, expected to grow to 8.3 billion USD by 2034 indicating broad expansion across hospitals, clinics and surgical. Fujifilm invested 65 million USD in Asia-Pacific manufacturing expansion during 2024, adding 5,000 units annual capacity.
By 2026, Asia-Pacific consolidated 42% of market share and 50%+ manufacturing capacity, while North America strengthened position in endotherapy devices hospitals and surgical. Medtronic announced 55 million USD U.S. facility upgrade in 2025, increasing capacity by 4,000 units annually.

Report Coverage of Endotherapy Devices Market

Report coverage spans global and regional analysis, technology breakdowns, application segments and competitive landscapes. Global endotherapy devices market valued at 4.5 billion USD in 2025 expected 8.3 billion USD by 2034 serves as quantitative baseline. Technology coverage includes GI Devices & Accessories (72% of value), ERCP Devices & Accessories (18%), Others (10%). Application analysis addresses hospitals (78%), clinics (18%), others (4%). Regional coverage details Asia-Pacific (42%), North America (35%), Europe (28%), Middle East & Africa (10%). Competitive sections profile Olympus (18%+ share) and Boston Scientific (16% share) in global endotherapy devices sales. Report includes 180 pages of analysis with 45 data tables and 32 charts covering market dynamics, production capacity, consumption trends and competitive positioning. Report analyzes 150 manufacturers globally across 45 countries with detailed production capacity data for 28 facilities. Market forecasts include 2025-2034 projections with annual consumption data by type and application.